Milestone Pharmaceuticals Inc. Proceeds from Sale of Short-term Investments
Milestone Pharmaceuticals Inc. (MIST) reported Proceeds from Sale of Short-term Investments of $29.00 million for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-29.
Discontinued › Cash Flow
us-gaap:ProceedsFromSaleOfShortTermInvestments · last filed 2023-03-29
- Milestone Pharmaceuticals Inc. proceeds from sale of short-term investments for the quarter ending 2020-12-31 was $16.00M.
- Milestone Pharmaceuticals Inc. proceeds from sale of short-term investments for the quarter ending 2019-09-30 was $5.00M.
- Milestone Pharmaceuticals Inc. proceeds from sale of short-term investments for fiscal 2022 was $29.00M, a 65.88% decline from fiscal 2021.
- Milestone Pharmaceuticals Inc. proceeds from sale of short-term investments for fiscal 2021 was $85.00M, a 325.00% increase from fiscal 2020.
- Milestone Pharmaceuticals Inc. proceeds from sale of short-term investments for fiscal 2020 was $20.00M.
| Period end | Proceeds from Sale of Short-term Investments 3 month | Proceeds from Sale of Short-term Investments 6 month | Proceeds from Sale of Short-term Investments 9 month | Proceeds from Sale of Short-term Investments 12 month |
|---|---|---|---|---|
| 2022-12-31 | $29.00M 10-K · filed 2023-03-29 | |||
| 2021-12-31 | $85.00M 10-K · filed 2023-03-29 | |||
| 2020-12-31 | $16.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-24 | $20.00M 10-K · filed 2022-03-24 | ||
| 2020-09-30 | $4.00M 10-Q · filed 2020-11-13 | |||
| 2019-09-30 | $5.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-13 | $5.03M 10-Q · filed 2020-11-13 | ||
| 2019-06-30 | $29.00K 10-Q · filed 2020-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Anixa Biosciences Inc (ANIX) | United States | $0.096B | |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B |